Dementias that occur over weeks to months require a different differential than the slowly progressive dementias that occur over years. Because of the rapidity of decline in cognition, the evaluation of the patient is usually urgent and requires an extensive workup with multiple tests running in parallel. Creutzfeldt-Jakob disease, perhaps the prototypic rapidly progressive dementia (RPD), is often the first diagnosis many neurologists consider when faced with a patient with rapid cognitive decline. Many conditions other than prion disease, however, can present with RPD. Other etiologies include autoimmune conditions, cancers, uncommon presentations of other more common neurodegenerative dementias, and others. This chapter discusses some of the major etiologies for RPDs and offers an algorithm for diagnosis. Some topics, such as other neurodegenerative dementias and autoimmune dementias, are covered in other chapters in this issue, and will be mentioned here only briefly.
INTRODUCTION
As neurologists, we are familiar with the differential diagnoses of slowly progressive dementias, such as typical Alzheimer disease (AD), frontotemporal degeneration (FTD), vascular dementia, Parkinson disease with dementia, and dementia with Lewy bodies (DLB). The diagnosis of rapidly progressive dementias (RPDs), however, entails a different diagnostic approach. Although there is no clear definition for the time frame of an RPD, here I use the term to refer to conditions that progress from first symptom to dementia (cognitive decline with functional impairment) in less than 1 to 2 years, although they are generally much faster. This chapter presents some of the major adult-onset causes of RPDs and proposes some diagnostic algorithms, including Creutzfeldt-Jakob disease (CJD).
The history of the nomenclature for CJD is quite interesting. In 1921 and 1923, Alfons Jakob published four papers describing five unusual cases of RPD. He stated that his cases were nearly identical to a case described earlier by his professor, Hans Creutzfeldt, in 1920. This disease was referred to for many decades as Jakob or Jakob-Creutzfeldt disease until Clarence J. Gibbs, a prominent researcher in the field, started using the term Creutzfeldt-Jakob disease because the acronym was closer to his own initials. 1 It turns out that the cases that Jakob described were very different than Creutzfeldt's case and that only two of Jakob's five cases actually had the disease that we now call CJD, whereas Creutzfeldt's case did not. 2 Thus, the name of the prion disease probably should be Jakob disease or Jakob-Creutzfeldt disease. Unfortunately, the terms JC disease or JCD currently may be confused with the conditions caused by the JC virus, progressive multifocal leukoencephalopathy. Therefore, unfortunately we continue to use the term CJD for Jakob disease.
Rapidly Progressive Dementias
Referred to Creutzfeldt-Jakob Disease Centers My experience with RPDs stems in part from my work evaluating patients with prion (pree-ahn) diseases. Over the past 8 years, more than 1400 suspected prion cases have been referred to our RPD program and dementia clinic at the University of California, San Francisco. The distribution of diagnoses for these referrals through July 1, 2009 , is shown in Figure 2 -1A. Of all RPD cases referred to our center (Figure 2-1A) , about onefourth came for an inpatient or outpatient evaluation (Figure 2-1B) ; for the others, we often conducted a detailed record review and communicated with the families, patients, and/or their physicians. The ''non-CJD/nonprion'' diagnostic group comprises almost 25% of all referrals; the diagnoses of patients with nonprion RPDs who were referred to UCSF, as well as a comparison group from the German CJD Surveillance Unit, are shown in Table 2 -1. 3, 4 Figure 2 -1B shows the diagnostic distribution for the subset of referred patients who were evaluated in person at our center. Many of the patients referred for potential sporadic CJD (sCJD) were found to have nonprion diagnoses when evaluated in person at our center.
At our center, most of the suspected CJD cases that were ultimately diagnosed with a nonprion RPD were, in decreasing frequency, other neurodegenerative diseases, neurologic autoimmune conditions, unclassified dementia, psychiatric illness, and other forms of encephalitis. Several patients had leukoencephalo-pathies of unclear etiology, some of whom had brain biopsies showing only nonspecific astrogliosis. Several of the psychiatric cases were self-referred patients in their twenties or thirties with anxiety and depression who thought they had variant CJD (vCJD) but had a normal neurologic examination. A few patients had Hashimoto encephalopathy (see chapter''Immunotherapy-ResponsiveDementias and Encephalopathies''). 3, 5 Despite the fact that pleocytosis is very rare in prion disease, several patients with meningoencephalitis were referred as having suspected CJD. In only a few patients with encephalitis was the agent identified (HIV, Lyme, and enterovirus). 5
Diagnostic Approach
In evaluating patients with RPDs, it is helpful to have a systematic, but thorough, approach to the diagnostic plan. One useful mnemonic for this differential evaluation of RPDs is the acronym VITAMINS ( Table 2- 2) . Several tests required for a comprehensive assessment are listed in Table 2-3 .
Initial Evaluation
RPDs are rare and can be difficult to diagnose. Oftentimes, however, identifying the first symptoms of a dementia can offer clues to diagnosis. This is particularly true of the neurodegenerative dementias, which often commence in specific neuroanatomic regions. 6, 7 Autoimmune limbic encephalopathies typically present with memory loss and/or behavioral changes. Viral encephalopathies or acute demyelinating encephalomyelitis may be preceded by a flulike illness. Once a condition is ascertained to be an RPD, the following tests are generally required: It is particularly important to rule out a simple metabolic perturbation or infection, particularly in elderly patients or those with a preexisting mild dementia, as these patients sometimes experience a rapid decline in these circumstances. Certain treatable and/or reversible conditions, such as autoimmune diseases, HIV, and Lyme disease, should always be considered. HIV can occur in anyone; there should be a low threshold for testing for these treatable conditions, even if the likelihood is low. Elevated CSF IgG index or oligoclonal bands (OCBs) might indicate an autoimmune process, such as paraneoplastic conditions or other neuroautoimmune processes. Although elevated OCBs and/or IgG index can occur in CJD, 8 their presence probably should prompt an autoimmune and paraneoplastic evaluation. In our UCSF CJD-RPD cohort, we identified several patients with RPD who had either elevated IgG index or OCBs and the presence of novel antineuronal antibodies in their serum and/or CSF. Although some had cancer, in many, no cancers were identified despite thorough evaluation. 5, 9 For a patient with an undiagnosed RPD after the initial workup, a body CT scan with and without contrast should be performed and examined for malignancy or sarcoid, in particular. If a CT is not initially feasible, start with a chest x-ray. For patients with suspected CJD or a rapidly progressive dementia, consider sending 14-3-3, neuron-specific enolase, and total tau, although as discussed below, these tests probably are markers of rapid neuronal injury and are neither sensitive nor specific for CJD. With the exception of lymphomas, RPDs that present with space-occupying brain masses are easily identified by CT or MRI scan, and the details of most of these disorders are omitted from this chapter. We start by discussing what many consider the prototypic RPD: CJD.
36

PRION DISEASES
What Are Prion Diseases? CJD is caused by the transformation of the normal cellular prion protein, PrP C (C stands for the normal cellular form), into an abnormal, disease-causing conformation, called the prion PrP Sc in which Sc stands for scrapie, the prion disease of sheep and goats, which accumulates in neurons. Prions were named and discovered by Stanley Prusiner, who received the 1997 Nobel Prize in Physiology or Medicine for his work in the 10 Prusiner postulates that prions act as templates that promote the conformational change in adjacent, normalshaped prion proteins into prions. When a PrP Sc comes into contact with a PrP C , it transforms the normal prion protein, PrP C , into PrP Sc , resulting in two prions. These two prions in turn transform two more PrP C into PrP Sc , which then transform four more, leading to an exponential transformation and accumulation of prions. It is believed that both the transformation of prion proteins into prions and the accumulation of prions lead to neurodegeneration. Recent data, however, suggest that it is the process of transformation of PrP C into PrP Sc , or possibly an intermediate conformation, and not the accumulation of PrP Sc , that leads to neuronal injury. 11
Background on Human Prion Diseases
Human prion diseases occur in most populations at a rate of 1 to 1.5 cases per million per year. 12 In the United States, with a population of about 300 million, about 300 cases of prion disease occur per year. Three forms of human prion diseases exist: (1) sporadic, (2) genetic, and (3) acquired. About 85% of human prion diseases are sporadic, 15% are genetic, and less than 1% are acquired. 13 Sporadic CJD, which occurs spontaneously and without a known cause, reportedly has a mean survival of 4 to 8 months, with 90% of patients dying within 1 year. The peak age of onset is 55 to 75 years old, with median age of onset of 68 and mean of 61 years. 14 Sporadic forms of prion disease include sCJD and the exceedingly rare sporadic fatal insomnia. Genetic or familial forms are due to autosomal dominant mutations in the PRNP gene encoding the prion protein. Acquired prion diseases are caused by iatrogenic or oral transmission of an abnormally shaped prion protein from an affected indi-vidual, or from an affected animal, to a person. 15 
Diagnosis of Sporadic Jakob-Creutzfeldt Disease
Histopathologic changes in CJD include nerve cell loss, gliosis, and vacuolation (formerly called spongiform change). Classically, pathologic (definite) diagnosis of prion disease requires identification of the protease-resistant PrP Sc with immunohistochemistry. 16 A new, rare form of sCJD has recently been identified in which the PrP Sc is relatively sensitive to protease digestion. 17 Several clinical diagnostic criteria exist for probable sCJD, 18 although the most commonly used are the 1998 Revised World Health Organization ( Table 2- 4) . 19 The following list indicates problems with most of these criteria:
(1) Visual and cerebellar symptoms are often combined (in Revised World Health Organization 1998 19 and some other criteria), although clinically, pathologically, and anatomically they are often separate. (2) They typically only allow diagnosis at the late stages of disease. (3) They do not include MRI, which has been shown to be very sensitive and specific for sCJD. (4) They may allow the use of the 14-3-3 protein in the CSF, which is still a subject of some controversy. 20 (5) They do not include other symptoms often found early on in CJD, such as psychiatric and behavioral symptoms and certain cortical signs, such as aphasia, apraxia, and neglect, to name a few. 6, 21 At UCSF, we are currently using modified diagnostic criteria ( Table 2-4) . These criteria, which are still in flux, include the use of brain MRI, not CSF biomarkers. Recently, a European CJD consortium proposed new criteria for CJD that include brain MRI (as well as the CSF 14-3-3 protein); however, they allow the use of either DWI or FLAIR MRI. 22 Additionally, their criteria do not include the identification of cortical ribboning in the frontal lobes, which, in sCJD, is one of the most commonly affected areas on MRI. This particular exclusion is due to air-brain artifact in these regions (eg, anterior cingulate) in many MR scanners. In my experience, however, artifact seen in certain brain regions usually can be dealt with by scanning in both axial and coronal planes. Indeed, when reading an MRI, particularly for CJD, one must always consider whether the findings are artifactual. This recommendation that it is possible to use only FLAIR MRI troubles me for a two reasons. (1) DWI is much more sensitive than FLAIR for detecting sCJD abnormalities. 23 (2) I have seen many patients whose FLAIR MRIs had findings that overlap with those seen in CJD, but whose DWI/ADC sequences did not show these findings. These patients usually had nonprion disorders, often treatable autoimmune encephalopathies. 3, 24 The EEG findings that can aid in the diagnosis of sCJD are periodic epileptiform discharges occurring at a frequency of approximately 1 Hz. Early in the course of sCJD, the EEG is often normal or shows focal slowing. As the disease progresses, more diffuse slowing occurs. In two-thirds of sCJD cases, the EEG ultimately reveals 1-Hz periodic epileptiform discharges, but this often requires serial EEG testing. 25 Although these EEG findings have relatively high specificity for CJD, they can also be seen in other conditions such as hepatic encephalopathy and rarely in end stages of some other neurodegenerative diseases, such as Alzheimer disease and dementia with Lewy bodies. 4 The reported utility of CSF biomarkers, 14-3-3, neuron-specific enolase (NSE), and total tau for CJD diagnosis is controversial. A lot of literature suggests relatively high sensitivities and specificities for these CSF biomarkers. It is important to note, however, that these biomarkers are not prion specific and do not identify prions. Our UCSF data suggest that these CSF markers do not have very high sensitivity for CJD ( Table 2-5) . Although, total tau and NSE have relatively high specificity in this cohort (Table 2-5), they still fall short to MRI (see later discussion). Recall that 1-minus specificity is the false-positive rate. This means that the 14-3-3 was false-positive in 26%, NSE in 11%, and total tau in 5% of nonprion RPD subjects tested. Therefore, a positive test certainly does " RAPIDLY PROGRESSIVE DEMENTIA not mean that a patient has CJD. Subjects with false-positive total tau levels often have toxic-metabolic conditions, including extrapontine myelinolysis, diabetic hyperglycemia with seizures, other seizure disorders, as well as strokes. Making diagnosis even more difficult was that some of these cases with false-positive total tau in the CSF had MRI features consistent with CJD, including cortical ribboning or basal ganglia hyperintensity on FLAIR, DWI, and ADC sequences. Unlike CJD, however, these patients and their MRIs often improved. When considering a CJD or RPD diagnosis, I recommend sending several markers of neuronal injury: 14-3-3, NSE, and total tau (consider including phosphorylated tau and A42 if AD is in the differential [''Alzheimer Disease Update'' chapter]). I test for these biomarkers for two reasons: (1) As markers of rapid neuronal injury, if elevated, this can confirm the history of a rapid dementia, as opposed to a sudden decline in a more slowly progressive dementia, such as AD, corticobasal degeneration, or DLB. (2) I send these CSF biomarkers to determine the utility of these tests in clinical practice. The only way we will determine whether these tests are useful is to acquire data. Remember that these tests do not confirm or refute a CJD diagnosis. 3, 5, 20 MRI, including FLAIR and particularly DWI, is very helpful in the diagnosis of CJD and sometimes has better sensitivity than brain biopsy and initial autopsy for CJD diagnosis. 26 Initial studies, using patients with standard dementia as controls, have found a sensitivity of DWI/ FLAIR MRI for CJD of 91% to 2%, and specificity of 94% to 5%. 23, 27 Abnormal hyperintensity can be seen on FLAIR and especially DWI MRI in the cortical gyri (cortical ribboning), caudate, putamen, and/or thalamus. A classic sCJD MRI with cortical and basal ganglia hyperintensity is shown in Figure 2 -2 (Case 2-1). The T2 image (not shown) typically shows very subtle hyperintense abnormalities, and often only in the deep gray nuclei; cortical ribboning is difficult to see because of adjacent CSF hyperintensity. FLAIR sequences show these basal ganglia abnormalities more clearly than standard T2 sequences, but the DWI sequence is best for seeing all of the abnormal hyperintensities found in CJD, particularly the cortical ribboning. In CJD, the DWI hyperintensities are due to restricted diffusion and thus are often hypointense (dark) on the ADC map. This restricted diffusion is due to PrP Sc deposition, vacuolation, or a combination of the two. 28 When using DWI/ADC sequences, the cortex is more commonly involved than the basal ganglia, which in turn is more often involved than the thalamus. 23, 29, 30 Not all sCJD cases, however, have these typical DWI and FLAIR MRI changes. 31 If a patient is strongly suspected to have CJD, but the MRI does not show the characteristic cortical ribboning and/or subcortical hyperintensity, and other conditions have been ruled out, consider testing for genetic prion disease (gPrD) before proceeding to brain biopsy (see later
Case 2-1
A 57-year-old right-handed woman with a history of hypertension and sleep disorder developed nonspecific personality changes. Three months later, her chronic insomnia worsened. Four months after onset, she became fidgety, paranoid, obsessive, and compulsive. She developed aberrant repetitive motor behavior. Visual hallucinations and illusions developed 6 months after onset. She began speaking to her image in the mirror, stealing compulsively, and driving dangerously. Ten months into her course, when she looked in a mirror, she thought she was looking at her sister wearing the same dress. She had episodes of wandering. Twelve months after onset, she was admitted to a psychiatric hospital and placed on olanzapine, lithium, and fluvoxamine. She showed a rapid global cognitive decline with motor slowing and incontinence. Over 1 year, she had unintentionally lost 9 kg. There was no family history of neurologic or psychiatric disease; her parents died in their seventies.
On examination 17 months after onset, she spoke in short phrases and was echolalic. She scored 1/30 on the Mini-Mental State Examination. She had full strength, increased tone, and poor rapid alternating movements (left worse than right), left-sided myoclonus, and a parkinsonian gait. Her EEG showed diffuse slowing/disorganization, focal left hemisphere slowing/attenuation, and generalized sharp discharges, consistent with encephalopathy. Her CSF showed normal cell counts, glucose, 14-3-3, intermediate NSE of 28, but elevated total tau (greater than 1200 pg/mL). FLAIR, DWI, and ADC brain MRI showed abnormalities consistent with CJD ( Figure 2-2 ). PRNP mutation testing was negative. Tests for other causes of RPD were unrevealing. She passed away from pathology-proven sCJD 20 months after onset.
Comment. This case illustrates several aspects of sCJD. Behavioral features are common first symptoms. 6 The course of CJD can be quite variable, sometimes lasting more than 2 years. Multiple brain regions are typically affected. DWI MRI is more sensitive than FLAIR for detecting sCJD abnormalities. CSF biomarkers are less sensitive than MRI. Extensive cortical ribboning is noted best on DWI (hyperintensity) and ADC (hypointensity) sequences (suggesting restricted diffusion); the findings are quite subtle on FLAIR. Two areas commonly affected on MRI in CJD are the caudate and putamen (solid arrows) and posterior cingulate/precuneus (dashed arrows). The orbital frontal (dotted arrow) and right greater than left frontal involvement may explain her profound behavioral changes. Her language difficulty is consistent with left-greater-than-right temporal lobe involvement (arrowheads). Her vision and visuospatial abnormalities may be explained by her occipital and posterior medial temporal lobe (not shown) abnormalities. In our experience, the relatively less basal ganglia involvement is consistent with a slower disease course. MRI = magnetic resonance imaging; CJD = Creutzfeldt-Jakob disease; DWI = diffusion-weighted imaging; ADC = apparent diffusion coefficient; FLAIR = fluid-attenuated inversion recovery.
" RAPIDLY PROGRESSIVE DEMENTIA discussion). The presence of the ''pulvinar sign,'' in which the pulvinar is more hyperintense than the anterior putamen on T2, distinguishes vCJD from sCJD, although this sign occasionally can be seen in sCJD. 32 The so-called doublehockey stick sign, with bilateral hyperintensity of the medial and posterior (pulvinar) thalamus is seen in several forms of prion disease, including sCJD and vCJD.
As CJD is the prototypic RPD, we will discuss what features should make one either consider or rule out CJD. Because CJD affects many areas of the brain, it presents in varied ways, often with protean neurologic manifestations. Because it can present like many other neurologic or psychiatric conditions, diagnosis can be difficult. For this reason, I call CJD ''the great mimicker.'' Table 2-6 33 lists several signs, symptoms, and laboratory findings commonly seen in sCJD, as well as findings that would be uncommon for CJD and should suggest ruling out other potential etiologies. The frequency of first, or initial, symptoms in CJD ( Table 2-7) is not drastically different from ''early symptoms'' that were reported in the literature as having occurred by the time of first neurologic evaluation, which is typically several weeks or months into the disease course. 6 First symptoms are the initial symptoms, whereas early are those that were present after weeks or months of illness. Although generally not discussed in the literature, the earliest features of CJD are often behavioral or psychiatric, such as personality changes, apathy, and depression. In our cohort sCJD, 3 the cognitive initial symptoms were distributed into memory loss (45%), executive dysfunction (13%), dysphasia (13%), and confusion. Cerebellar symptoms more often related to gait or balance (84%) than to limb ataxia (12%). Among constitutional symptoms, the most common were vertigo or dizziness (41%), fatigue (21%), and A CJD is the great mimicker-it can look like many other entities early in the course. sleep disorders (10%). 6 Table 2-8 suggests some conditions to consider in the differential of CJD; many cases referred to our center as potential CJD have turned out to have one of these conditions. We also have had cases referred as having some of these conditions that turned out to be CJD.
Genetic and Variant CJD
Although this discussion of human prion diseases has focused on sCJD, the most common form of CJD, both vCJD and genetic prion disease (gPrD) should be considered. Genetic forms, including familial CJD, Gerstmann-Sträussler-Scheinker, and fatal familial insomnia, are caused by more than 40 known mutations in the prion gene. These mutations make the existing prion protein PrP more susceptible to transformation into PrP Sc . 10 [37] [38] [39] Genetic cases, depending on the mutation and other polymorphisms, can present identically to sCJD (in terms of clinical features, time course, MRI, and EEG) (Figure 2-3) or with a prolonged course of over a few years, with cognitive changes, behavioral changes, ataxia, and/or parkinsonism without typical MRI and EEG features as well as without family history. More than 60% of genetic cases have no known family history of CJD, although families often report a history of ''Alzheimer'' or ''Parkinson'' disease (Case 2-2). 34 As of October, 2009, 214 cases of vCJD have been identified, the vast majority occurring in the United Kingdom, " RAPIDLY PROGRESSIVE DEMENTIA followed by France. Although three cases of vCJD have been diagnosed in the United States, none is believed to have been acquired in the United States. Compared to sCJD, vCJD tends to affect younger people, with a mean age of onset of about 28 years old (range 12 to 74 years), and has a longer duration of illness (mean of 14 months). The EEG in vCJD generally does not show the classic 1-Hz periodic epileptiform discharges that are seen often in sCJD cases. T2weighted MRI typically shows the pulvinar sign, which occurs when the pulvinar (posterior thalamus) appears brighter than the anterior putamen. Most cases of vCJD start with a psychiatric prodrome of several months before neurologic symptoms develop. A clinical diagnosis of vCJD relies on the overall clinical picture, including EEG and MRI. Definite diagnosis of vCJD is made pathologically by biopsy (tonsil or brain) or autopsy and can often be differentiated clinically from sCJD. Unlike other forms of prion disease, vCJD has been shown to be transmitted by blood transfusion (www. cjd.ed.ac.uk). 40 
NONPRION ACUTE AND SUBACUTE DEMENTIAS
Several of these conditions fall into more than one etiologic category-paraneoplastic conditions, for example, are both autoimmune and neoplastic. In addition, not all conditions mentioned present as dementia but may have other rapidly progressive neurologic signs, such as ataxia or chorea. I will discuss the remaining nonprion RPDs in the order of the mnemonic VITAMINS ( Table 2 -2).
Vascular
Vascular conditions that might lead to RPDs include strokes or multiple infarcts, cerebral amyloid angiopathy, and hypertensive encephalopathy. 41 Vasculitis and intravascular lymphoma can also lead to RPDs. Even small focal strokes, particularly in the thalamus, can cause acute dementia. 42, 43 DWI and gradient-echo (hemosiderin-sensitive sequence) MRI as well as vascular imaging such as MR angiography and CT angiography can help diagnosis vascular etiologies for dementia.
Infectious
Most infectious causes of encephalopathy have certain features, such as fever, pleocytosis, meningeal signs (if a meningoencephalitis), and acute onset over days, which help determine the etiology. CSF, however, may be normal. When viral encephalitis is suspected, herpes simplex virus (HSV) should be ruled out with HSV PCR from CSF, which may need to be tested through repeat lumbar punctures. 44 If the etiology of a suspected infectious encephalopathy or encephalitis is not identified quickly, both acute and convalescent serum and CSF should be saved to help with later identification of the infectious Continuum Lifelong Learning Neurol 2010;16(2) 47 FIGURE 2-3 Brain MRI (1.5-tesla magnet) on a patient with familial Creutzfeldt-Jakob disease (CJD) (E200K PRNP mutation) shows areas of DWI hyperintensity, often with corresponding ADC hypointensity, suggesting restricted diffusion. Multiple regions of cortical ribboning are present, including the left-greater-than-right parietal cortex (arrowheads), right-greater-than-left anterior (dotted arrows), and posterior (dashed arrows) cingulate gyri. Restricted diffusion appears in the right-greater-than-left caudate and putamen (solid arrows). As is typical in CJD, the abnormalities are more evident on DWI than FLAIR; additionally, the ADC map reveals more regions of restricted diffusion than are evident on DWI. Note that the MRI findings in this patient with familial CJD are similar to those seen in sporadic CJD. In many E200K patients, the caudate and putamen are more hyperintense than the cortex, although this also can occur in other forms of CJD. MRI = magnetic resonance imaging; CJD = Creutzfeldt-Jakob disease; DWI = diffusion-weighted imaging; ADC = apparent diffusion coefficient; FLAIR = fluid-attenuated inversion recovery.
KEY POINT
A Compared to sporadic CJD, variant CJD tends to affect younger people (mean age of onset 28 years, range 12 to 74 years, has a longer duration of illness, and does not have the classic EEG findings. Patients often have the pulvinar sign on MRI (the pulvinar is brighter than the anterior putamen).
agent. In the United States, the state health departments of California, New York, and Tennessee all have divisions, funded in part by the US Center for Disease Control and Prevention, to help diagnose various encephalitides. Other states and federal laboratories may also examine acute and convalescent serum and CSF. Unfortunately, for most cases of encephalitis, the etiology is never found. Among over 300 referrals to the California Encephalitis Project over a 2.5-year period, 62% of cases re-mained unexplained, 45 although some cases recently have been found to be due to anti-NMDA-receptor antibodies (see ''Immunotherapy-Responsive Dementias and Encephalopathies'' chapter). It is particularly important to rule out HIV 46, 47 and, depending on the location, Lyme disease or other local infectious agents, such as Balamuthia in California, most of which are treatable. 48 Fungal infections, such as aspergillosis, may also cause RPD, although usually only in immunocompromised patients.
Continuum Lifelong Learning Neurol 2010;16(2)
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Case 2-2
A 50-year-old right-handed woman reported to her gynecologist cognitive difficulty she had been having for the past year that she had attributed to menopause. Her sister noted she had difficulty ''putting her thoughts together'' when speaking. Over the next few weeks colleagues noted she developed problems functioning at work. She particularly demonstrated memory and difficulty with organizational tasks. After leaving the office, she would return several times because she had forgotten items to bring home. Her cognitive function then declined rapidly. She was disoriented and had great difficulty expressing herself, discussing her day-to-day tasks and how she had spent her day. Her personality changed from stubborn, take-charge, and aggressive to meek and mouselike. She could not complete sentences and became lost walking around town. She developed slowed movement. Her family history was negative for dementia or psychiatric illness (her parents died in their seventies from cancer and heart attack). Three siblings (two older) were healthy with no neurologic symptoms. On neurologic examination 2 months later, 14 months after onset of cognitive difficulty, her Mini-Mental State Examination was 23/30, with points lost for memory and orientation. She had mild upper limb ataxia and a mildly wide-based gait. She had problems with ''go-no-go'' tasks. Her CSF showed no cells, normal protein, glucose, IgG index, and no OCBs; no CSF biomarkers were sent. EEG showed focal slowing but no sharp waves. Brain MRI showed asymmetric basal ganglia and cortical hyperintensities on FLAIR and DWI consistent with CJD (Figure 2-3) . The rest of her RPD evaluation, including rheumatologic, antithyroperoxidase, and antithyroglobulin antibodies; paraneoplastic panel (including voltage-gated potassium channel antibody); and a body CT scan were normal or negative. She was diagnosed with sCJD and died that month from pathology-proven CJD. Her PRNP gene test done prior to death, however, later showed an E200K mutation. Her diagnosis was changed to familial CJD.
Comment. gPrD can present very similarly to sCJD, and not all PRNP mutations are 100% penetrant. The length of disease course of the patient in Case 2-2 is similar to that in Case 2-1; yet Case 2-2 was genetic despite no clear positive family history. This case stresses the importance of testing for PRNP mutations in all CJD cases, as well as considering the possibility in undiagnosed dementias.
KEY POINT
A If the etiology of a suspected infectious encephalopathy or encephalitis is not identified quickly, both acute and convalescent serum and CSF should be saved to help with later identification of the infectious agent.
" RAPIDLY PROGRESSIVE DEMENTIA Although Whipple disease classically presents with gastrointestinal symptoms, lymphadenopathy, fever, and arthralgias, neurologic involvement occurs in 5% to 45% of cases and can be the presenting symptom. Symptoms of CNS Whipple disease often include cognitive and behavioral dysfunction, hemiparesis, seizures, and ataxia. As Whipple disease is rare, but treatable with antibiotics, one should test for the bacteria Tropheryma whipplei by PCR from the blood, CSF, jejunal biopsy, or brain biopsy if indicated 49, 50 Other infections to consider are shown in Tables 2-2 and 2-8.
Toxic-Metabolic
Identification of toxic causes of encephalopathy requires a thorough medication and exposure history that includes inquiry about work and home environments. Elevated lithium, often iatrogenic, can cause encephalopathy. In adults, inorganic lead typically leads to peripheral neuropathy; in children, however, cognitive impairment and encephalopathy can occur. Compared with inorganic lead, even minimal exposure to organic lead, a gasoline additive, is toxic. Such exposure may cause psychiatric and behavioral symptoms, including agitation, disturbed sleep patterns, and hallucinations. Similar to lead toxicity, inorganic and organic mercury can lead to very toxic syndromes, such as the Mad Hatter syndrome, which was caused by inorganic mercury exposure in industrial settings and was marked by tremor and psychological disturbance. Organic mercury exposure, possibly due to grain contamination or industrial exposure, leads to a triad of concentric visual field loss, paresthesias, and cerebellar ataxia, but no tremor. Although commonly assessed in a heavy metal screen, acute arsenic toxicity does not cause RPD but rather early gastrointestinal and circulatory problems, followed weeks later by a length-dependent sensorimotor polyneuropathy and desqua-mation of palms and soles. 51 When suspecting heavy metal exposure, a 24-hour urine test (not a spot urine) and possibly a hair and/or nail analysis should be considered. Bismuth used in excess to treat gastrointestinal illnesses (bismuth subsalicylate or Pepto-Bismol in the United States; colloidal bismuth subcitrate or De-Nol in Europe) can cause an acute dementia, and even mimic CJD. Symptoms of bismuth toxicity include cognitive dysfunction (memory loss, confusion, poor concentration, depression, auditory and visual hallucinations, and even encephalopathy), as well as tremor, ataxia, dysarthria, and myoclonus. A careful history and bismuth level testing can ascertain diagnosis. Symptoms are often reversible if caught early enough. 3, 52, 53 Too many metabolic disorders result in adult-onset dementia to be discussed in this chapter. Some important reversible categories, however, are vitamin deficiencies and endocrinologic dysfunction. Niacin deficiency, or pellagra (rough skin), is often described as the three Ds: dermatitis, diarrhea, and dementia. A niacin deficiency will occur without an exogenous source (except in pregnant women, who are able to convert tryptophan into niacin). Niacin deficiency results in abnormalities of the skin, gastrointestinal tract, and the peripheral and central nervous systems. Neurologic deficits can include peripheral neuropathy, myelopathy, and subacute cognitive deficits. Other nutritional deficiencies often occur in conjunction with pellagra. Niacin deficiency occurs most commonly in nutritionally deprived patients (eg, alcoholic, malnourished, impoverished), and in association with systemic disorders, including diabetes mellitus, neoplasms, chronic infections, cirrhosis, chronic gastrointestinal or diarrheal illnesses, and thyrotoxicosis. In industrialized nations, pellagra is most often seen in alcoholics and in patients taking isoniazid. Clinical diagnosis is made on suspicion, ruling out other etiologies, and then treating patients empirically (40 mg/d to 250 mg/d niacin), usually resulting in improvement of neurologic symptoms. 54, 55 Deficiency of thiamine (vitamin B 1 ), a necessary cofactor in oxidative metabolism, can cause Wernicke encephalopathy. Wernicke encephalopathy classically presents as an acute/subacute dementia with ophthalmoparesis (with vertical and/or horizontal nystagmus), ataxia, and memory loss. Pathologically, hemorrhagic necrosis of the mammillary bodies or dorsomedial nucleus of the thalamus may be detected on MRI. DWI hyperintensity, including restricted diffusion on ADC maps may be present 56 and can resemble MRI findings seen in CJD. Lastly, all patients with a dementia should be screened for vitamin B 12 deficiency, as the clinical deficits are potentially reversible.
Thyroid dysfunction is a well-known cause of cognitive impairment. All patients with RPD deserve a basic thyroid function screen. Depending on the clinical scenario, other endocrine dysfunction should also be considered. It is prudent to include basic electrolytes (including serum calcium, magnesium, and phosphorus levels) and kidney and liver function in any dementia screen. Some other metabolic conditions that I have seen mimic sCJD are adult-onset seizure disorders, due to severe hyperglycemia or other causes, and extrapontine myelinolysis due to rapid correction of hyponatremia. These conditions can also have DWI and ADC MRI findings comparable to those seen in CJD, including basal ganglia hyperintensity and/or cortical ribboning.
Autoimmune
As seen in our RPD cohort ( Table 2-1) , several autoimmune conditions present as RPDs. These are discussed in detail in the chapter ''Immunotherapy-Responsive Dementias and Encephalopathies,'' so they will be discussed here only briefly. For most RPDs, I generally do a basic autoimmune screen, which typically includes erythrocyte sedimentation rate, C-reactive protein, antinuclear antibody, cytoplasmic antineutrophil cytoplasmic antibody, perinuclear antineutrophil cytoplasmic antibody, Sjögren syndrome A, Sjögren syndrome B, rheumatoid factor, CSF IgG index, OCBs, and other tests, depending on the clinical scenario. It would be unusual to find a normal MRI in the setting of a CNS vasculitis. Unfortunately, most cases of CNS vasculitis have normal serologic findings. 47 MRI may show contrast enhancement, infarcts, and involvement of gray and/or white matter. 3, 5 When MRI and the clinical picture suggest vasculitis, it is important to note that other conditions, such as intravascular lymphoma, can have the appearance of vasculitis on brain angiogram and may also respond to steroids, albeit temporarily. Depending on the clinical situation, particularly if serum lactate dehydrogenase is elevated (seen in lymphoma), it may be best to rule out other etiologies. In such cases, brain tissue or CSF cytology/flow cytometry might provide more definitive diagnosis. When performing a brain biopsy for potential vasculitis, it is important to take an appropriately sized piece of tissue (typically 1 cm x 1 cm x 1 cm), including meninges, ideally from an area that is abnormal on MRI. 47 In the setting of a rapidly progressive cerebellar ataxia and mild cognitive impairment, anti-glutamic acid decarboxylase, 65 isoform (GAD65) antibodies (and celiac sprue) should be considered. Due to its often rapid progression, anti-GAD65 may be mistaken for CJD. As with other non-CJD RPDs, this condition can have elevated CSF 14-3-3 protein. It is important to recognize as anti-GAD65 is treatable with steroids or other immunomodulatory treatments. Anti-GAD65 antibody can be associated with neoplasms, so a cancer workup should be done. 3, 57 Continuum Lifelong Learning Neurol 2010;16(2)
KEY POINT
A When MRI and the clinical picture suggest vasculitis, it is important to note that other conditions, such as intravascular lymphoma, can have the appearance of vasculitis on brain angiogram and may also respond to steroids.
If a paraneoplastic or antibody mediated dementia syndrome is suspected in a patient who has none of the known or commercially available antibodies, one may wish to send blood and/or CSF to a research laboratory that specializes in identifying novel antibodies.
Neurodegenerative/Neoplastic
Neurodegenerative conditions other than CJD may present as RPDs. Many patients referred to our center with an RPD diagnosis did not have an RPD, but rather a slowly progressive neurodegenerative dementia. People closest to the patient, particularly when with the patient daily, often had missed the first signs of illness and had not brought the patient to a doctor until the symptoms became obvious or a sudden steep decline occurred. These declines were sometimes part of the natural disease course and other times due to an infection (eg, urinary tract infection, pneumonia) or another metabolic perturbation. Determination of a non-RPD dementia diagnosis was typically made by obtaining history from friends, colleagues, or family members who did not see the patient regularly and had noticed cognitive changes well before those who saw the patient on a daily basis. 3, 5 Nevertheless, some nonprion neurodegenerative dementias can rarely progress rapidly, even over 1 to 3 years, from first symptom to death. These include corticobasal degeneration, frontal temporal degeneration, frontotemporal degenerationmotor neuron disease, and rare cases of AD and DLB. [3] [4] [5] These conditions are discussed elsewhere in this issue (chapters ''Alzheimer Disease Update,'' ''Parkinsonian Dementias,'' and ''Frontotemporal Degeneration'').
Neoplastic causes of RPD can be quite difficult to diagnose. Primary CNS lymphoma and intravascular lymphoma often present as RPD and even may resemble CJD clinically (Case 2-3). MRI can be helpful in making these diagnoses (Figure 2-4) . 58 In lymphoma, serum lactate dehydrogenase may be elevated, although this is nonspecific. As noted earlier, if brain angiogram shows a pattern indistinguishable from vasculitis in a patient with RPD, pathology and/or CSF cytology may be the necessary and preferred diagnostic method. When considering CNS lymphoma, repeated large volume CSF analyses for cytology and flow cytometry should be done, even though they are often negative. 47 Avoid giving steroids if a biopsy is being considered, as this will result in the necrosis of the lymphoma cells, rendering pathologic diagnosis difficult to impossible. When a neoplastic condition is in the differential, a thorough general medical examination, a chest/abdomen/pelvis CT (with and without contrast), and possibly a full body PET scan should be considered, depending on the clinical context.
Systemic
There are too many systemic conditions that can present as RPDs to discuss in detail here, but a few to consider are shown in Table 2 -2. 3,5 In a patient with an unexplained multisystem disorder, consider mitochondrial disease, particularly if gray and white matter MRI abnormalities or clinical features consistent with mitochondrial disease are present. Systems frequently affected are the peripheral nervous system (myopathy, polyneuropathy, lactacidosis), brain (leukoencephalopathy, calcifications, strokes, seizures, upper motor neuron findings, ataxia, extrapyramidal symptoms, unexplained fatigue), endocrine (short stature, pubertal abnormalities), cardiac (conduction defects, cardiomyopathy, unexplained heart failure), visual (early cataracts, retinopathy, optic atrophy), auditory (deafness, vertigo), gastrointestinal (dysphagia, nausea/vomiting, diarrhea, liver abnormalities, pancreas insufficiency), kidney (renal failure, cysts) and bone marrow (sideroblastic anemia). 59 Mitochondrial dementia may rarely present acutely. 60 An unusual pattern of neurologic disease in the family may also be a clue to mitochondrial disease.
CONCLUSION
The evaluation of a patient with an RPD can be challenging and time-consuming.
It is therefore important to have a structured approach to the diagnostic evaluation. Remember the basics: an uncommon presentation of a common condition is more likely than an uncommon condition. When in doubt or when dealing with a very complicated RPD case, consider inpatient evaluation for an expeditious workup.
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Case 2-3
A 55-year-old right-handed man developed increasing daytime fatigue, followed 1 month later by left facial numbness and mild apathy. Two months after onset, he felt unsteady on his feet, had transient scalp pain, and developed a sudden-onset left facial droop, which was treated with acyclovir for Bell palsy. Six months after onset, he developed problems with long-term memory, judgment, dysarthria, and worsening gait ataxia. MRI on admission (Figure 2-4 ) revealed multiple T2 hyperintensities in the basal ganglia, cerebellum, and around the fourth ventricle, with mild contrast enhancement. Multiple CSF analyses revealed mild pleocytosis, elevated IgG index, and multiple OCBs. Cytologies and flow cytometries revealed only atypical lymphoid cells with irregular nucleoli. Extensive rheumatologic/autoimmune (including sprue, anti-GAD, sarcoid, and paraneoplastic), neoplastic (including serum lactate dehydrogenase [LDH], body PET, CT, gallium scan), and infectious workup were all negative. The [ 18 F]fluorodeoxyglucose-PET scan showed only increased uptake in the cerebellum. A tongue ulcer biopsy showed only inflammation. Ophthalmic evaluation with fluorescein angiography showed cotton-wool spots (attributed to old infection), but no uveitis or vasculitis was present. As the neurosurgeons refused to perform a biopsy because of the location of his brain lesions, an empiric course of IV steroids was administered without benefit. Seven months into his course, repeat MRIs revealed new contrast-enhancing lesions near the ventricles. Brain biopsy revealed large anaplastic T-cell lymphoma, which did not respond to treatment. As his lymphoma progressed, his serum LDHs eventually became markedly elevated.
Comment. CNS lymphomas can be very difficult to diagnose, often requiring brain biopsy. Multiple CSF analyses for cytology and flow cytometry are often required, but may not provide a definitive diagnosis. In this patient, findings were suggestive of, but none conclusive for, CNS lymphoma until brain biopsy. 
